The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Glomerulonephritis Treatment Market - 2024-2031
US$ 3,400.00
Glomerulonephritis Treatment Marketis is growing with a CAGR of 5.40% during the forecast period 2026-2035. The Glomerulonephritis Treatment Market emerges as a key focus in DataM Intelligence latest...
February 2024
54 pages
Metronidazole Capsule Market - 2024-2031
US$ 3,400.00
The Metronidazole Capsule Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver un...
February 2024
47 pages
Vitamins and Supplements Markets in China
US$ 4,000.00
China's demand for Vitamins and Supplements has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
February 2024
200 pages
Anti Dermatomycosis Skin Drugs Markets in China
US$ 4,000.00
China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
February 2024
221 pages
Anti Peptic Ulcer Drugs Markets in China
US$ 4,000.00
China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
February 2024
211 pages
Sleep Disorder Treatment Drugs Markets in China
US$ 4,000.00
China's demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
February 2024
227 pages
Anti Dermatomycosis Skin Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Anti Dermatomycosis Skin Drugs industry forecasts. In the ... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s ... The primary and secondary research is done in China in order to access up-to-date government regulations, ...
February 2024
100 pages
Sleep Disorder Treatment Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Sleep Disorder Treatment Drugs industry forecasts. In the ... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s ... The primary and secondary research is done in China in order to access up-to-date government regulations, ...
February 2024
114 pages
Vitamins and Supplements Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Vitamins and Supplements industry forecasts. In the two past decades, ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
February 2024
91 pages
Anti Dermatomycosis Skin Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Anti Dermatomycosis Skin Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
February 2024
71 pages
Sleep Disorder Treatment Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Sleep Disorder Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
February 2024
61 pages
Vitamins and Supplements Companies in China
US$ 1,800.00
This study focuses on China’s Vitamins and Supplements industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
February 2024
60 pages
Tendinitis Treatment Market - 2024-2031
US$ 3,400.00
Tendinitis Treatment Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Tendinitis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
February 2024
46 pages
Arthritic Therapeutic Market By Product Type (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, Others), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Others): Global Opportunity Analysis and Industry Forecast, 2022 - 2032
US$ 3,570.00
The arthritic therapeutic market was valued at $79.5 billion in 2022 and is estimated to reach $136.1 billion by 2032, exhibiting a CAGR of 5.5% from 2023 to 2032. Arthritis therapeutics involves a co...
February 2024
250 pages
Immunosuppressants Drugs Market - 2024-2031
US$ 3,400.00
Immunosuppressants Drugs Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Immunosuppressants Drugs Market emerges as a key focus in DataM Intelligence latest in-depth...
February 2024
50 pages
Pompe Disease Treatment Market by Treatment (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Chaperone-Advanced Replacement Therapy (CART), and Others), Route of Administration (Oral, Intravenous, and Others), Distribution Channel (Hospital and Clinics Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Indication Type (Infantile-Onset Pompe Disease (IOPD), Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Pompe Disease (LOPD), and Others), and Region 2024-2032
US$ 2,999.00
The global Pompe disease treatment market size reached US$ 1.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.5...
January 2024
142 pages
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032
US$ 2,999.00
The global systemic lupus erythematosus (SLE) drugs market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth r...
January 2024
142 pages
Analgesics Market Report by Type (Prescription, Over-The-Counter (OTC)), Drug Class (Opioids, NSAIDs, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns, Dental/Facial, Pediatric, and Others), Application (Internal, External), and Region 2024-2032
US$ 2,999.00
The global analgesics market size reached US$ 54.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 77.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 20...
January 2024
149 pages
Emtricitabine and Tenofovir Market - 2024-2031
US$ 3,400.00
Emtricitabine and Tenofovir Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Emtricitabine and Tenofovir Market emerges as a key focus in DataM Intelligence latest in...
January 2024
53 pages
Ampicillin Market - 2024-2031
US$ 3,400.00
The Ampicillin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
January 2024
36 pages
Anosmia Market - 2024-2031
US$ 3,400.00
The Anosmia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled mar...
January 2024
33 pages
Hereditary Angioedema Therapeutics Market - 2024-2031
US$ 3,400.00
Hereditary Angioedema Therapeutics Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Hereditary Angioedema Therapeutics Market emerges as a key focus in DataM Intellig...
January 2024
60 pages
Urea Cycle Disorder Treatment Market - 2024-2031
US$ 3,400.00
The Urea Cycle Disorder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
January 2024
55 pages
Plasma Protease C1-Inhibitor Treatment Market - 2024-2031
US$ 3,400.00
The Plasma Protease C1-Inhibitor Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
January 2024
64 pages
Urinary Tract Infection Therapeutics Market - 2024-2031
US$ 3,400.00
The Urinary Tract Infection Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresigh...
January 2024
62 pages
Microscopic Polyangiitis (MPA) Treatment Market - 2024-2031
US$ 3,400.00
Microscopic Polyangiitis (MPA) Treatment Marketis is growing with a CAGR of 5.50% during the forecast period 2026-2035. The Microscopic Polyangiitis (MPA) Treatment Market emerges as a key focus in Da...
January 2024
66 pages
Polycystic Kidney Disease Market - 2024-2031
US$ 3,400.00
Polycystic Kidney Disease Market reached US$ 769 million in 2031 and, growing with a CAGR of 5.80% during the forecast period 2031-2035. The Polycystic Kidney Disease Market emerges as a key focus in...
January 2024
51 pages
South America Constipation Market - 2024-2031
US$ 2,499.00
South America Constipation Market reached in and is expected to reach by , growing with a CAGR of 0.00% during the forecast period 2026-. The South America Constipation Market emerges as a key focus...
January 2024
53 pages
Candidiasis Therapeutics Market - 2024-2031
US$ 3,400.00
Candidiasis Therapeutics Marketis is growing with a CAGR of 5.30% during the forecast period 2026-2035. The Candidiasis Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth...
January 2024
50 pages
Scleroderma Therapeutics Market - 2024-2031
US$ 3,400.00
Scleroderma Therapeutics Marketis is growing with a CAGR of 5.98% during the forecast period 2026-2035. The Scleroderma Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth...
January 2024
50 pages
Spain Opioid Induced Constipation Market - 2024-2031
US$ 1,899.00
Spain Opioid Induced Constipation Market reached in and is expected to reach by , growing with a CAGR of 4.40% during the forecast period 2026-. The Spain Opioid Induced Constipation Market emerges as...
January 2024
59 pages
Von Willebrand Disease Treatment Market - 2024-2031
US$ 3,400.00
Von Willebrand Disease Treatment Market reached US$ 728.1 million in 2031 and, growing with a CAGR of 6.50% during the forecast period 2031-2035. The Von Willebrand Disease Treatment Market emerges as...
January 2024
58 pages
Acute Lung Injury Market - 2024-2031
US$ 3,400.00
Acute Lung Injury Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The Acute Lung Injury Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
January 2024
43 pages
Global Markets for Generic Drugs
US$ 4,650.00
The global market for generic drugs should reach $533 billion by 2021 ... from 2016 to 2021. The BRIC markets region of the generic drugs industry is the largest market. The market is expected to grow from $132 ... 2016-2021. The North America region of the generic drugs industry is expected to grow from $112 billion ...
January 2024
126 pages
Exocrine Pancreatic Insufficiency Market - 2024-2031
US$ 3,400.00
Exocrine Pancreatic Insufficiency Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Exocrine Pancreatic Insufficiency Market emerges as a key focus in DataM Intelligen...
January 2024
59 pages
Fondaparinux Market - 2024-2031
US$ 3,400.00
The Fondaparinux Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...
January 2024
38 pages
Acromegaly Treatment Market - 2024-2031
US$ 3,400.00
Acromegaly Treatment Market reached US$ 2.1 billion in 2031 and, growing with a CAGR of 7.40% during the forecast period 2031-2035. The Acromegaly Treatment Market emerges as a key focus in DataM Inte...
January 2024
46 pages
Fatty Acid Oxidation Disorder Drugs Market - 2024-2031
US$ 3,400.00
The Fatty Acid Oxidation Disorder Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
January 2024
61 pages
Pompe Disease Therapeutics Market - 2024-2031
US$ 3,400.00
Pompe Disease Therapeutics Market reached USD 1.9 billion in 2031 and, growing with a CAGR of 4.30% during the forecast period 2031-2035. The Pompe Disease Therapeutics Market emerges as a key focus i...
January 2024
52 pages
Non-Opioid Pain Treatment Market - 2024-2031
US$ 3,400.00
Non-Opioid Pain Treatment Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Non-Opioid Pain Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
January 2024
51 pages
Overactive Bladder Treatment Market - 2024-2031
US$ 3,400.00
Overactive Bladder Treatment Marketis is growing with a CAGR of 3.60% during the forecast period 2026-2035. The Overactive Bladder Treatment Market emerges as a key focus in DataM Intelligence latest...
January 2024
54 pages
IgG4-Related Disease Market - 2024-2031
US$ 3,400.00
The IgG4-Related Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
January 2024
46 pages
Osteoarthritis Drugs Market - 2024-2031
US$ 3,400.00
Osteoarthritis Drugs Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Osteoarthritis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analys...
January 2024
47 pages
Global Markets for Orphan Drugs
US$ 4,650.00
Report : The scope of this study includes orphan drugs used in the global pharmaceutical markets. This report analyzes the therapeutic applications of orphan drugs in rare and orphan diseases as well...
January 2024
189 pages
Cryoglobulinemia Treatment Market - 2024-2031
US$ 3,400.00
The Cryoglobulinemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
December 2023
52 pages
Cold Agglutinin Disease Treatment Market - 2024-2031
US$ 3,400.00
The Cold Agglutinin Disease Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight t...
December 2023
59 pages
Paget's Disease Market - 2024-2031
US$ 3,400.00
The Paget's Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
December 2023
41 pages
